| scholarly article | Q13442814 |
| P50 | author | Christian Hölscher | Q37831053 |
| Peter R. Flatt | Q39048924 | ||
| Victor A. Gault | Q39188087 | ||
| P2093 | author name string | D W Porter | |
| B D Kerr | |||
| P2860 | cites work | The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice | Q38363214 |
| Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats | Q47291712 | ||
| P433 | issue | 10 | |
| P921 | main subject | obesity | Q12174 |
| insulin resistance | Q1053470 | ||
| liraglutide | Q2526479 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 891-899 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Diabetes, Obesity and Metabolism | Q5270109 |
| P1476 | title | Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance | |
| P478 | volume | 12 |
| Q44476616 | (Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed mice |
| Q57816534 | 12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus |
| Q101219733 | Bidirectional modulation of hippocampal and amygdala synaptic plasticity by post-weaning obesogenic diet intake in male rats: Influence of the duration of diet exposure |
| Q58713445 | Brain metabolic and functional alterations in a liver-specific PTEN knockout mouse model |
| Q34639384 | Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model |
| Q27321064 | Dietary Reversal Ameliorates Short- and Long-Term Memory Deficits Induced by High-fat Diet Early in Life |
| Q37210037 | Effects of diabetes on hippocampal neurogenesis: links to cognition and depression |
| Q28710367 | Energy intake and exercise as determinants of brain health and vulnerability to injury and disease |
| Q48864779 | Exenatide enhances cognitive performance and upregulates neurotrophic factor gene expression levels in diabetic mice |
| Q27009988 | Food for thought: the role of appetitive peptides in age-related cognitive decline |
| Q38860011 | GPR39 receptors and actions of trace metals on pancreatic beta cell function and glucose homoeostasis. |
| Q37929159 | Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents |
| Q35070673 | Glucagon-like peptide-1, diabetes, and cognitive decline: possible pathophysiological links and therapeutic opportunities. |
| Q33850466 | High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice |
| Q21131756 | High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity |
| Q38606226 | Hippocampal insulin resistance and cognitive dysfunction |
| Q51817883 | IQ is an independent predictor of glycated haemoglobin level in young and middle-aged adults with intellectual disability. |
| Q38197368 | Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases |
| Q33567304 | Laboratory animals as surrogate models of human obesity |
| Q58781043 | Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia |
| Q90074752 | Liraglutide Suppresses Tau Hyperphosphorylation, Amyloid Beta Accumulation through Regulating Neuronal Insulin Signaling and BACE-1 Activity |
| Q38324750 | Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice. |
| Q38189558 | Neuroendocrine link between stress, depression and diabetes |
| Q38583347 | Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease |
| Q41221501 | Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration |
| Q34290086 | Obesity-Related Hormones in Low-Income Preschool-Age Children: Implications for School Readiness |
| Q35558707 | Obesity-associated biomarkers and executive function in children |
| Q38039489 | Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection |
| Q47769365 | RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes |
| Q58790854 | Rapid and reversible impairment of episodic memory by a high-fat diet in mice |
| Q33854353 | Recruiting adaptive cellular stress responses for successful brain ageing |
| Q64102382 | Regulation of Memory Function by Feeding-Relevant Biological Systems: Following the Breadcrumbs to the Hippocampus |
| Q48379621 | Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline |
| Q53841357 | Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus. |
| Q36651084 | Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits |
| Q51373857 | Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4 |
| Q58610182 | The effect of body mass index on glucagon-like peptide receptor gene expression in the post mortem brain from individuals with mood and psychotic disorders |
| Q26768527 | The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action |
| Q35801796 | The lighter side of BDNF. |
| Q36395944 | Thidoredxin-2 overexpression fails to rescue chronic high calorie diet induced hippocampal dysfunction. |
| Q26824702 | Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales |
| Q45378064 | Xenin-25[Lys13PAL]: a novel long-acting acylated analogue of xenin-25 with promising antidiabetic potential |
Search more.